$10.7 Million Revenue, Pharm & Biotech Consulting Firm
Pharm Biotech Consulting Firm Founded in 1993 with FDA Expertise
On NextCompany since August 28, 2026 (today)
Location undisclosedEstablished 1993
Business overview
The consulting firm assists pharmaceutical companies with statistical data analysis. It supports clinical research reporting and helps clients secure FDA drug approvals. Founded in 1993, the firm operates in Pennsylvania and California. Projected 2024 revenue reaches $10,700,000 with $2,400,000 EBITDA. The owner pursues semi-retirement and will assist during transition.
Who is a good fit for this business
- Buyers targeting pharmaceutical consulting firms match this established operation.
- Acquirers seeking statistical analysis support for clinical research fit the client base.
- Groups interested in FDA approval assistance providers suit the service model.
Details
- Reason for selling
- The owner is pursuing the sale to semi-retire and concentrate on other businesses he has ownership in.
Frequently Asked Questions
The firm provides statistical data analysis and reporting for clinical research. It assists pharmaceutical companies seeking new drug approvals from the FDA. Clients consist of pharmaceutical and biotech companies.
The firm reached $10.4 million in revenue with $1.7 million EBITDA in 2023. Projected 2024 revenue totals $10,700,000 with $2,400,000 EBITDA.
The firm operates in Pennsylvania and California. The owner will assist with transition and may remain as consultant.
The owner pursues the sale to semi-retire. The owner will concentrate on other businesses. The owner ensures new buyers meet key clients during transition.